|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA; Department of Pharmacology and Cell Biophysics, University of Cincinnati, Cincinnati, Ohio, USA
2 Department of Pediatrics, Children's Hospital Medical Center, Cincinnati, Ohio, USA
3 Department of Molecular and Cellular Physiology, and Division of Cardiology, University of Cincinnati College of Medicine and Noninvasive Cardiac Imaging and Hemodynamic Research Laboratory, Cincinnati, Ohio, USA
4 Department of Physiology and Cell Biology, The Ohio State University, Columbus, Ohio, USA
5 Department of Internal Medicine Division of Cardiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
6 Department of Molecular Genetics, Biochemistry and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
7 Department of Internal Medicine Division of Cardiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA; Department of Physiology and Cell Biology, The Ohio State University, Columbus, Ohio, USA
* To whom correspondence should be addressed. E-mail: periasamy.1{at}osu.edu.
We recently developed a mouse model with a single functional allele of Serca2 (+/-) which show impaired cardiac contractility and relaxation without overt heart disease. The goal of this study was to test the hypothesis that chronic reduction in SERCA2 levels in combination with an increased hemodynamic load will result in an accelerated pathway to heart failure. Age matched Wildtype and Serca2+/- mice were subjected to 10 weeks of pressure overload via transverse aortic coarctation surgery. Cardiac hypertrophy and heart failure were assessed using Echocardiography, gravimetry/histology, hemodynamic, and western blotting analyses. Our results showed that ~64% of coarcted Serca2+/- mice were in heart failure compared to 0% of coarcted wildtype mice (p<0.05). Overall, morbidity and mortality were greatly increased in Serca2+/- mice under pressure overload. Echocardiography assessment revealed a significant increase in LV mass, and LV hypertrophy in coarcted Serca2+/- mice converted from a concentric to an eccentric pattern, similar to that seen in human heart failure. Coarcted Serca2+/- mice had decreased contractile/systolic and relaxation/diastolic performance/function compared to coarcted wildtype mice (p<0.05), despite a similar duration and degree of pressure overload. SERCA2a protein levels were significantly reduced (>50%) in coarcted Serca2+/- mice compared to noncoarcted and coarcted wildtype mice. Our findings suggest that reduction in SERCA2 levels in combination with an increased hemodynamic load result in an accelerated pathway to heart failure.
This article has been cited by other articles:
![]() |
M. Brini and E. Carafoli Calcium Pumps in Health and Disease Physiol Rev, October 1, 2009; 89(4): 1341 - 1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Prasad and G. Inesi Effects of thapsigargin and phenylephrine on calcineurin and protein kinase C signaling functions in cardiac myocytes Am J Physiol Cell Physiol, May 1, 2009; 296(5): C992 - C1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hilal-Dandan, H. He, J. L. Martin, L. L. Brunton, and W. H. Dillmann Endothelin downregulates SERCA2 gene and protein expression in adult rat ventricular myocytes: regulation by pertussis toxin-sensitive Gi protein and cAMP Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H728 - H734. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vinet, P. Rouet-Benzineb, X. Marniquet, N. Pellegrin, L. Mangin, L. Louedec, J.-L. Samuel, and J.-J. Mercadier Chronic doxycycline exposure accelerates left ventricular hypertrophy and progression to heart failure in mice after thoracic aorta constriction Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H352 - H360. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Vinge, P. W. Raake, and W. J. Koch Gene Therapy in Heart Failure Circ. Res., June 20, 2008; 102(12): 1458 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. H. Talukder, A. Kalyanasundaram, L. Zuo, M. Velayutham, Y. Nishijima, M. Periasamy, and J. L. Zweier Is reduced SERCA2a expression detrimental or beneficial to postischemic cardiac function and injury? Evidence from heterozygous SERCA2a knockout mice Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1426 - H1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Periasamy, P. Bhupathy, and G. J. Babu Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology Cardiovasc Res, January 15, 2008; 77(2): 265 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lassmann, J. Sliwoski, A. Chang, D. A. Canning, and S. A. Zderic Deletion of one SERCA2 allele confers protection against bladder wall hypertrophy in a murine model of partial bladder outlet obstruction Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R58 - R65. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Prasad, H. Ma, C. Sumbilla, D. I. Lee, M. G. Klein, and G. Inesi Phenylephrine hypertrophy, Ca2+-ATPase (SERCA2), and Ca2+ signaling in neonatal rat cardiac myocytes Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2269 - C2275. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Kennedy, S. Vetteth, M. Xie, S. M. Periyasamy, Z. Xie, C. Han, V. Basrur, K. Mutgi, V. Fedorov, D. Malhotra, et al. Ouabain decreases sarco(endo)plasmic reticulum calcium ATPase activity in rat hearts by a process involving protein oxidation Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H3003 - H3011. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. R. Carvalho, R. A. Bassani, K. G. Franchini, and J. W. M. Bassani Enhanced calcium mobilization in rat ventricular myocytes during the onset of pressure overload-induced hypertrophy Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1803 - H1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Mounkes, S. V. Kozlov, J. N. Rottman, and C. L. Stewart Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice Hum. Mol. Genet., August 1, 2005; 14(15): 2167 - 2180. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Baek and M. Weiss Down-Regulation of Na+ Pump {alpha}2 Isoform in Isoprenaline-Induced Cardiac Hypertrophy in Rat: Evidence for Increased Receptor Binding Affinity but Reduced Inotropic Potency of Digoxin J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 731 - 739. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |